NATCOPHARM Intraday Analysis...

NATCOPHARM Share Price

Open 1035.00 Change Price %
High 1050.00 1 Day -0.55 -0.05
Low 1014.05 1 Week 92.25 9.90
Close 1023.65 1 Month 119.10 13.17
Volume 503062 1 Year 434.10 73.63
52 Week High 1090.00
52 Week Low 555.05
NATCOPHARM Important Levels
Resistance 2 1056.98
Resistance 1 1043.24
Pivot 1029.23
Support 1 1004.06
Support 2 990.32
NSE INDIA Most Active Stocks
JPASSOCIAT 17.55 -0.28%
RCOM 11.85 -0.42%
FCONSUMER 67.85 6.93%
VEDL 298.00 4.73%
UNITECH 6.55 -1.50%
3IINFOTECH 4.60 -1.08%
ICICIBANK 303.15 -0.39%
GMRINFRA 17.20 2.08%
YESBANK 315.90 3.95%
BOMDYEING 266.75 16.84%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
RJL 275.45 20.00%
ALPA 38.40 20.00%
CANTABIL 99.45 19.96%
BOMDYEING 266.75 16.84%
RAJRAYON 0.35 16.67%
TTL 93.70 14.97%
NILAINFRA 24.80 13.76%
SQSBFSI 551.15 13.67%
SREEL 214.20 12.94%
More..
NSE INDIA Top Losers Stocks
MAHABANK 21.00 -18.45%
UVSL 0.40 -11.11%
NAKODA 0.40 -11.11%
REFEX 23.85 -9.83%
PRAKASHCON 5.50 -8.33%
KESARENT 64.75 -7.83%
CORALFINAC 61.50 -7.03%
LCCINFOTEC 0.70 -6.67%
CELESTIAL 18.85 -6.22%
SUMEETINDS 29.95 -6.11%
More..

Natco Pharma Limited (NSE: NATCOPHARM)

NATCOPHARM Technical Analysis 5
As on 15th Dec 2017 NATCOPHARM Share Price closed @ 1023.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 870.22 & Strong Buy for SHORT-TERM with Stoploss of 945.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
NATCOPHARM Target for December
1st Target up-side 1005.43
2nd Target up-side 1050.87
3rd Target up-side 1096.31
1st Target down-side 875.77
2nd Target down-side 830.33
3rd Target down-side 784.89
NATCOPHARM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is Above 70 Over Bought
MFI (14) MFI is 78.73 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 926.89
10 Day Avg Volume Traded 54.86 % More then 10 Day Average Volume
NATCOPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NATCOPHARM Address
NATCOPHARM
N/A
NATCOPHARM Latest News
Natco Pharma - Natco receives Generic Sofosbuvir (Sovaldi) approval for India   Moneycontrol.com   - 12th Mar 15
NATCO Pharma stock rises most on US court ruling   Business Today   - 11th Mar 15
Buy Natco Pharma; target of Rs 1920: ICICIdirect   Moneycontrol.com   - 11th Mar 15
UPDATE 1-India's Natco Pharma ties up with Gilead on hepatitis C drugs   Reuters   - 02nd Mar 15
Natco Pharma - Q3 results on Feb 11, 2015   Moneycontrol.com   - 30th Jan 15
Natco Pharma dips on preferential share allotment at discount   Business Standard   - 17th Dec 14
Natco Pharma CFO passes away   Hindu Business Line   - 23rd Oct 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir.)   JD Supra (press release)   - 25th Jul 14
Gilead Sciences, Inc. v. Natco Pharma Limited   Lexology (registration)   - 08th May 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)   Patent Docs   - 29th Apr 14
Interactive Technical Analysis Chart Natco Pharma Limited ( NATCOPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Natco Pharma Limited
NATCOPHARM Business Profile
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,439.26 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director. It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.